Abstract
In the United States, schools closed in March 2020 due to COVID-19 and have begun reopening as of August 2020, despite continuing transmission of SARS-CoV-2. To determine the impact of school reopening with varying levels of operating capacity and face-mask adherence, we used an agent-based model calibrated to and validated against multiple data types from the state of Indiana, USA. In our model, transmission can occur in schools, workplaces, community settings, and households, all of which are structured in a realistic way according to state geography and demography. Using this model, we quantified the burden of COVID-19 on K-12 students, teachers, their families, and the general population under alternative scenarios about school reopening. In our primary analysis, we considered three levels of school operating capacity (50%, 75%, and 100%) and three assumptions about face-mask adherence in schools (50%, 75%, and 100%). Under a scenario in which schools operate remotely, we projected 45,579 (95% CrI: 14,109-132,546) infections and 790 (95% CrI: 176-1680) deaths between August 24 and December 31. Reopening at 100% capacity with 50% face-mask adherence in schools resulted in a proportional increase of 42.9 (95% CrI: 41.3-44.3) times that number of infections and 9.2 (95% CrI: 8.9-9.5) times that number of deaths. In contrast, operating at 50% capacity with 100% face-mask adherence resulted in only an 11% (95% CrI: 5%-18%) increase in the number of infections compared to the scenario in which schools operate remotely. We conclude that reduced capacity and high face-mask adherence in schools substantially reduce the burden of COVID-19, both among those with direct ties to schools and across the state. As Indiana and other states proceed with school reopening, our results illustrate quantitatively the benefits of safety measures that schools are undertaking, underscoring their value for both schools and their communities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by an NSF RAPID grant to TAP (DEB 2027718), an Arthur J. Schmitt Fellowship and Eck Institute for Global Health Fellowship to RJO, and a Richard and Peggy Notabaert Premier Fellowship to MP. We thank the University of Notre Dame Center for Research Computing for computing resources.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a simulation model and does not require IRB approval
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated manuscript to change the baseline assumptiono f face-mask protection from 0.15 adjusted OR to 0.3 (0.12 - 0.73) adjusted OR, based on the review of face-mask efficacy on a non-health-care setting. We also updated the assumptions to include an alternative assumption on the infectivity of asymptomatic infections to be half as infectious as symptomatic infections. In addition, we included an alternative scenario in which children aged 0-10 years have lower susceptibility.
Data Availability
The data is publicly available
